Valo Therapeutics Secures EUR 2.23 million from the European Innovation Council to Progress Innovative PeptiCHIP Technology

Valo Therapeutics Oy announced that it has secured funding of approximately EUR 2.23 millionfrom the European Innovation Council for a project to progress the company’s PeptiCHIP technology, which rapidly identifies a tumor’s antigen presentation profile to drive development of novel personalized immunotherapies.